» Articles » PMID: 28940167

Th2-biased Immune Response and Agglutinating Antibodies Generation by a Chimeric Protein Comprising OmpC Epitope (323-336) of Aeromonas Hydrophila and LTB

Overview
Journal Immunol Res
Date 2017 Sep 24
PMID 28940167
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Aeromonas hydrophila is responsible for causing fatal infections in freshwater fishes. Besides chemical/antibiotic treatment and whole-cell vaccine, no subunit vaccine is currently available for A. hydrophila. Outer membrane proteins of gram-negative bacteria have been reported as effective vaccine candidates. Peptide antigens elicit focused immune responses against immunodominant stretches of the antigen. We have attempted to characterize the immunogenicity of linear B-cell epitopes of outer membrane protein (OmpC) of A. hydrophila identified using in silico tools, in conjugation with heat-labile enterotoxin B (LTB) subunit of Escherichia coli as a carrier protein. Antisera against the fusion protein harboring 323-336 residues of the AhOmpC (raised in mice) showed maximum cross-reactivity with the parent protein OmpC and LTB. The fusion protein displayed efficient GM ganglioside receptor binding, retaining the adjuvanicity of LTB. Antibody isotype profile and in vitro T-cell response analysis, cytokine ELISA, and array analysis collectively revealed a Th2-biased mixed T-helper cell response. Agglutination assay and flow cytometry analysis validated the ability of anti-fusion protein antisera to recognize the surface exposed epitopes on Aeromonas cells, demonstrating its neutralization potential. Oral immunization studies in Labeo rohita resulted in the generation of long-lasting humoral immune response, and the antisera could cross-react with the fusion protein as well as both the fusion partners. Considering significant similarity among OmpC of different enteric bacteria, the use of A. hydrophila OmpC epitope in fusion with LTB could have a broader scope in vaccine design.

Citing Articles

Oral Live-Carrier Vaccine of Recombinant Lactococcus lactis Inducing Prophylactic Protective Immunity Against Helicobacter pylori Infection.

Ni X, Liu Y, Sun M, Jiang Y, Wang Y, Ke D Probiotics Antimicrob Proteins. 2024; .

PMID: 39251521 DOI: 10.1007/s12602-024-10360-x.


Immunogenic and neutralization efficacy of recombinant perfringolysin O of Clostridium perfringens and its C-terminal receptor-binding domain in a murine model.

Singh A, Rawat P, Choudhury D, Dixit A Immunol Res. 2022; 70(2):240-255.

PMID: 35032316 PMC: 8760870. DOI: 10.1007/s12026-021-09254-9.


Development, Biological Characterization, and Immunological Evaluation of Virosome Vaccine against Newcastle Disease in Pakistan.

Rasool M, Mehmood A, Saqalein M, Nisar M, Almatroudi A, Khurshid M Biomed Res Int. 2021; 2021:8879277.

PMID: 33575353 PMC: 7864732. DOI: 10.1155/2021/8879277.


Application of built-in adjuvants for epitope-based vaccines.

Lei Y, Zhao F, Shao J, Li Y, Li S, Chang H PeerJ. 2019; 6:e6185.

PMID: 30656066 PMC: 6336016. DOI: 10.7717/peerj.6185.

References
1.
Vila J, Ruiz J, Gallardo F, Vargas M, Soler L, Figueras M . Aeromonas spp. and traveler's diarrhea: clinical features and antimicrobial resistance. Emerg Infect Dis. 2003; 9(5):552-5. PMC: 2972757. DOI: 10.3201/eid0905.020451. View

2.
Purcell A, McCluskey J, Rossjohn J . More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov. 2007; 6(5):404-14. DOI: 10.1038/nrd2224. View

3.
Pruksakorn S, Currie B, Brandt E, Phornphutkul C, Hunsakunachai S, Manmontri A . Identification of T cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A streptococci. Int Immunol. 1994; 6(8):1235-44. DOI: 10.1093/intimm/6.8.1235. View

4.
Kaur M, Chug H, Singh H, Chandra S, Mishra M, Sharma M . Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis. Mol Immunol. 2009; 46(10):2107-15. DOI: 10.1016/j.molimm.2008.12.031. View

5.
Ferrante A, Beard L, Feldman R . IgG subclass distribution of antibodies to bacterial and viral antigens. Pediatr Infect Dis J. 1990; 9(8 Suppl):S16-24. View